UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4877-4883

2010

Volltextzugriff (PDF)

Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336

Journal of clinical oncology, 2009-01, Vol.27 (1), p.11-15

2009

Volltextzugriff (PDF)

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

Supportive care in cancer, 2013-04, Vol.21 (4), p.1185-1192

2013

Volltextzugriff (PDF)

Phase III Noninferiority Trial Comparing Irinotecan With Oxaliplatin, Fluorouracil, and Leucovorin in Patients With Advanced Colorectal Carcinoma Previously Treated With Fluorouracil: N9841

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2848-2854

2009

Volltextzugriff (PDF)

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

International journal of radiation oncology, biology, physics, 2006-07, Vol.65 (4), p.1106-1111

2006

Volltextzugriff (PDF)

Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7

Journal of clinical oncology, 2006-03, Vol.24 (9), p.1409-1414

2006

Volltextzugriff (PDF)

Randomized Phase II Study of Two Irinotecan Schedules for Patients With Metastatic Breast Cancer Refractory to an Anthracycline, a Taxane, or Both

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2849-2855

2004

Volltextzugriff (PDF)

Gemcitabine and ISIS-2503 for Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma: A North Central Cancer Treatment Group Phase II Trial

Journal of clinical oncology, 2004-12, Vol.22 (24), p.4944-4950

2004

Volltextzugriff (PDF)

Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5929-5937

2005

Volltextzugriff (PDF)

CHOD/BVAM Chemotherapy and Whole-Brain Radiotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma

International journal of radiation oncology, biology, physics, 2011-10, Vol.81 (2), p.476-482

2011

Volltextzugriff (PDF)

Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors

Journal of thoracic oncology, 2010-12, Vol.5 (12), p.1994-1998

2010

Volltextzugriff (PDF)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities

Radiation oncology (London, England), 2011-08, Vol.6 (1), p.91-91, Article 91

2011

Volltextzugriff (PDF)

A Phase II Trial of Nab-Paclitaxel (ABI-007) and Carboplatin in Patients With Unresectable Stage IV Melanoma: A North Central Cancer Treatment Group Study, N057E

Cancer, 2011-04, Vol.117 (8), p.1704-1710

2011

Volltextzugriff (PDF)

Phase 2 Trial of Carboplatin, Weekly Paclitaxel, and Biweekly Bevacizumab in Patients With Unresectable Stage IV Melanoma : A North Central Cancer Treatment Group Study, N047A

Cancer, 2009, Vol.115 (1), p.119-127

2009

Volltextzugriff (PDF)

Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes : NCCTG trial N01CC

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2836-2841

2006

Volltextzugriff (PDF)

Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study

Journal of clinical oncology, 2002-01, Vol.20 (2), p.567-573

Jatoi, A.

2002

Volltextzugriff (PDF)

Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial

American journal of clinical oncology, 2012-08, Vol.35 (4), p.329-333

2012

Volltextzugriff (PDF)

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

Mayo Clinic proceedings, 2006-06, Vol.81 (6), p.758-767

2006

Volltextzugriff (PDF)

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: A University of Rochester James P. Wilmot cancer center community clinical oncology program study of 360 cancer patients treated in the community

Cancer, 2003-06, Vol.97 (11), p.2880-2886

2003

Volltextzugriff (PDF)

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

Cancer, 2003-03, Vol.97 (6), p.1442-1446

2003

Volltextzugriff (PDF)

5-hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial

The lancet oncology, 2005-10, Vol.6 (10), p.765-772

2005

Volltextzugriff (PDF)

Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer

American journal of clinical oncology, 2014-04, Vol.37 (2), p.167-171

2014

Volltextzugriff (PDF)

Cancer patients' expectations of experiencing treatment-related side effects: A University of Rochester Cancer Center-Community Clinical Oncology Program Study of 938 patients from Community Practices

Cancer, 2004-08, Vol.101 (4), p.851-857

2004

Volltextzugriff (PDF)

Efficacy and Quality-of-Life Data Are Related in a Phase II Trial of Oral Chemotherapy in Previously Untreated Patients With Metastatic Colorectal Carcinoma

Journal of clinical oncology, 2002-12, Vol.20 (23), p.4574-4580

2002

Volltextzugriff (PDF)

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)

Lung cancer (Amsterdam, Netherlands), 2008-05, Vol.60 (2), p.200-207

2008

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(79)
Reviews
(4)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

Humans
(55)
Female
(50)
Middle Aged
(49)
Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Aged
(47)
Oncology
(44)
Male
(42)
Adult
(40)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Aged, 80 And Over
(26)
Treatment Outcome
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Tumors
(21)
Chemotherapy
(18)
Survival Analysis
(14)
Drug Administration Schedule
(13)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(11)
Quality Of Life
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

Phase III Noninferiority Trial Comparing Irinotecan With Oxaliplatin, Fluorouracil, and Leucovorin in Patients With Advanced Colorectal Carcinoma Previously Treated With Fluorouracil: N9841

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7

Randomized Phase II Study of Two Irinotecan Schedules for Patients With Metastatic Breast Cancer Refractory to an Anthracycline, a Taxane, or Both

Gemcitabine and ISIS-2503 for Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma: A North Central Cancer Treatment Group Phase II Trial

Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer

CHOD/BVAM Chemotherapy and Whole-Brain Radiotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma

Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities

A Phase II Trial of Nab-Paclitaxel (ABI-007) and Carboplatin in Patients With Unresectable Stage IV Melanoma: A North Central Cancer Treatment Group Study, N057E

Phase 2 Trial of Carboplatin, Weekly Paclitaxel, and Biweekly Bevacizumab in Patients With Unresectable Stage IV Melanoma : A North Central Cancer Treatment Group Study, N047A

Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes : NCCTG trial N01CC

Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study

Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: A University of Rochester James P. Wilmot cancer center community clinical oncology program study of 360 cancer patients treated in the community

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

5-hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial

Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer

Cancer patients' expectations of experiencing treatment-related side effects: A University of Rochester Cancer Center-Community Clinical Oncology Program Study of 938 patients from Community Practices

Efficacy and Quality-of-Life Data Are Related in a Phase II Trial of Oral Chemotherapy in Previously Untreated Patients With Metastatic Colorectal Carcinoma

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)

Suchergebnisse filtern